Walgreens Boots Alliance stock holds steady ahead of next earnings update
Published on 09/07/2026 at 15:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Walgreens Boots Alliance stock (ISIN US9314271019) is not trading on September 7, 2026 because the New York Stock Exchange and Nasdaq are closed for the US Labor Day holiday, with regular trading scheduled to resume on September 8, 2026 according to IndMoney.
Recent earnings frame the story
In the most recent reported quarter, Walgreens Boots Alliance published results that investors continue to use as a reference point for the stock, with figures for revenue and earnings per share setting the tone for expectations in the current fiscal year as reported in the company’s latest filings and earnings releases in 2026.
According to market data from major US financial portals, Walgreens Boots Alliance generated several billion dollars in quarterly revenue in its latest reported period in 2026, with earnings per share reflecting the pressure from reimbursement dynamics and front-store traffic, and with management confirming that this was the most recently published quarter as of September 7, 2026.
Guidance and margin dynamics
The latest guidance communicated by Walgreens Boots Alliance in 2026 points to modest earnings growth for the current fiscal year, with the company’s margin outlook shaped by cost-saving initiatives and investments in its healthcare services businesses.
Recent commentary from US analyst reports in early September 2026 indicates that consensus expectations for Walgreens Boots Alliance’s adjusted earnings per share remain tightly linked to management’s guidance corridor, with several houses highlighting that, compared with the previous fiscal year, the guidance implies a low- to mid-single-digit percent change in earnings.
Analyst views and key risks
US analysts covering Walgreens Boots Alliance stock have recently reiterated mixed views, with some emphasizing the long-term potential of the healthcare strategy and others warning about execution risks and competitive pressure from both traditional pharmacy rivals and online players.
Across recent notes compiled by financial portals during the first days of September 2026, the average analyst price target for Walgreens Boots Alliance stock stands moderately above the latest closing price from the last completed trading day, signaling cautious upside potential but also reflecting the risk that margins could be squeezed further if reimbursement rates or generic drug pricing move unfavorably.
Representative product and business model
Walgreens Boots Alliance derives a significant portion of its revenue from its core pharmacy operations and health and wellness products, including prescription dispensing and over-the-counter medications, as well as beauty and personal care items sold through its Walgreens and Boots store networks.
Stock status and market context
Because US equity markets are fully closed on September 7, 2026 for Labor Day as confirmed by IndMoney, Walgreens Boots Alliance stock is currently unchanged versus its prior close; investors must therefore rely on the last completed trading day’s closing price, 52-week trading range, volume and market capitalization data from leading US stock portals as of September 6, 2026 when assessing the stock’s latest performance.
Walgreens Boots Alliance stock at a glance
- Company: Walgreens Boots Alliance Inc.
- ISIN: US9314271019
- Ticker: WBA
- Trading venue: Nasdaq
- Sector / Industry: Health Care / Drug Retail
- Index membership: S&P 500
